Caixia Suo

1.3k total citations
17 papers, 895 citations indexed

About

Caixia Suo is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Caixia Suo has authored 17 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Caixia Suo's work include Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (4 papers) and IL-33, ST2, and ILC Pathways (3 papers). Caixia Suo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (4 papers) and IL-33, ST2, and ILC Pathways (3 papers). Caixia Suo collaborates with scholars based in China, United States and Poland. Caixia Suo's co-authors include Huafeng Zhang, Linchong Sun, Ping Gao, Shiting Li, Shengqi Shen, Ju Qiu, Tong Zhang, Liang Zhou, Weidong Jia and Xuemei Gu and has published in prestigious journals such as Nature Communications, Nature Immunology and Cancer Research.

In The Last Decade

Caixia Suo

16 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caixia Suo China	14	501	394	220	139	112	17	895
Eun-Jin Yeo United States	8	482 1.0×	305 0.8×	208 0.9×	81 0.6×	97 0.9×	9	909
Zeribe C. Nwosu United States	15	466 0.9×	295 0.7×	158 0.7×	106 0.8×	75 0.7×	22	884
Yingying Qian China	19	479 1.0×	319 0.8×	87 0.4×	162 1.2×	95 0.8×	43	904
Yuanjun Jiang China	18	365 0.7×	175 0.4×	115 0.5×	111 0.8×	88 0.8×	47	734
Liqiao Fan China	20	585 1.2×	423 1.1×	89 0.4×	205 1.5×	129 1.2×	71	965
Yingying Hao China	18	504 1.0×	209 0.5×	242 1.1×	103 0.7×	47 0.4×	48	874
Jilin Li China	17	453 0.9×	241 0.6×	131 0.6×	120 0.9×	74 0.7×	51	840
Chung‐Hsing Chen Taiwan	17	551 1.1×	224 0.6×	194 0.9×	78 0.6×	35 0.3×	35	886
Bojun Wang China	16	668 1.3×	437 1.1×	187 0.8×	144 1.0×	129 1.2×	34	1.1k
Chao‐Qun Hong China	16	434 0.9×	183 0.5×	96 0.4×	117 0.8×	95 0.8×	54	723

Countries citing papers authored by Caixia Suo

Since Specialization

Citations

This map shows the geographic impact of Caixia Suo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caixia Suo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caixia Suo more than expected).

Fields of papers citing papers by Caixia Suo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caixia Suo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caixia Suo. The network helps show where Caixia Suo may publish in the future.

Co-authorship network of co-authors of Caixia Suo

This figure shows the co-authorship network connecting the top 25 collaborators of Caixia Suo. A scholar is included among the top collaborators of Caixia Suo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caixia Suo. Caixia Suo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Li, Zhikun, Caixia Suo, Xuemei Gu, et al.. (2025). ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism. Journal of Molecular Cell Biology. 17(1).

Chen, Rui, Zhiyuan Lin, Shengqi Shen, et al.. (2024). Citrullination modulation stabilizes HIF-1α to promote tumour progression. Nature Communications. 15(1). 7654–7654. 11 indexed citations

Yan, Kai, Liang Chen, Rongrong Huang, et al.. (2024). Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8+ T cells in hepatocellular carcinoma. Journal of Hepatology. 81(4). 690–703. 25 indexed citations

Yan, Ronghui, Shengqi Shen, Yu Zeng, et al.. (2024). Carnosine regulation of intracellular pH homeostasis promotes lysosome-dependent tumor immunoevasion. Nature Immunology. 25(3). 483–495. 28 indexed citations

Sun, Linchong, Caixia Suo, Tong Zhang, et al.. (2023). ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism. Nature Chemical Biology. 19(12). 1492–1503. 30 indexed citations

Gu, Xuemei, Haoran Wei, Caixia Suo, et al.. (2023). Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustion. Nature Communications. 14(1). 8154–8154. 41 indexed citations

Suo, Caixia, Haoran Wei, Xuemei Gu, et al.. (2022). Mitochondrion-Localized SND1 Promotes Mitophagy and Liver Cancer Progression Through PGAM5. Frontiers in Oncology. 12. 857968–857968. 18 indexed citations

Liu, Zhaoji, Linchong Sun, Yongping Cai, et al.. (2021). Hypoxia-Induced Suppression of Alternative Splicing of MBD2 Promotes Breast Cancer Metastasis via Activation of FZD1. Cancer Research. 81(5). 1265–1278. 42 indexed citations

Wu, Gongwei, Caixia Suo, Ying Yang, et al.. (2021). MYC promotes cancer progression by modulating m ⁶ A modifications to suppress target gene translation. EMBO Reports. 22(3). e51519–e51519. 33 indexed citations

10.

Wang, Yinghui, Hui Lü, Linchong Sun, et al.. (2021). Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase. Cell Death and Disease. 12(10). 902–902. 13 indexed citations

11.

Zhang, Tong, Linchong Sun, Yijie Hao, et al.. (2021). ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. Nature Cancer. 3(1). 75–89. 138 indexed citations

12.

Deng, Tian, Caixia Suo, Rui Yang, et al.. (2019). ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice. Cellular and Molecular Immunology. 17(2). 163–177. 34 indexed citations

13.

Zhang, Tong, et al.. (2019). Hypoxia and Metabolism in Metastasis. Advances in experimental medicine and biology. 1136. 87–95. 60 indexed citations

14.

Hu, Lan, Zheng Yang, Caixia Suo, et al.. (2019). 2-Oxonanonoidal Antibiotic Actinolactomycin Inhibits Cancer Progression by Suppressing HIF-1α. Cells. 8(5). 439–439. 3 indexed citations

15.

Sun, Linchong, Caixia Suo, Shiting Li, Huafeng Zhang, & Ping Gao. (2018). Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1870(1). 51–66. 289 indexed citations

16.

Cai, Ting, Jinxin Qiu, Yanhui Ma, et al.. (2018). IL-17–producing ST2+ group 2 innate lymphoid cells play a pathogenic role in lung inflammation. Journal of Allergy and Clinical Immunology. 143(1). 229–244.e9. 96 indexed citations

17.

Suo, Caixia, Zhiqin Fan, Liang Zhou, & Ju Qiu. (2017). Perfluorooctane sulfonate affects intestinal immunity against bacterial infection. Scientific Reports. 7(1). 5166–5166. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact